Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “formulation”

865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 865
Index total 30,257
Page 21 / 37

Quick answer

This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

865 results for “formulation” · 30,257 patents in full index Clear search

  1. US 10195275

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  2. US 10195151

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Jazz Pharmaceuticals International III Limited · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  3. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  4. US 2019008774

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME

    BIAL PORTELA & Cª S A [PT] · Granted Jan 10, 2019 · Expires Jan 5, 2039

    granted

  5. US 10166219

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    RedHill Biopharma Ltd. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  6. US 10159732

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  7. US 10159733

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  8. US 10155039

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  9. US 10149853

    Stabilized formulations of CNS compounds

    Supernus Pharmaceuticals, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  10. US 10143751

    Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  11. US 10137186

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  12. US 10131659

    Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases; formulations thereof; and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  13. US 10123974

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  14. US 10117936

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  15. US 10117938

    Pharmaceutical formulation

    Semnur Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  16. US 10117831

    Soft chew pharmaceutical formulations

    First Time US Generics LLC · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  17. US 10111925

    Formulations comprising plant extracts

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  18. US 10111912

    Herbal formulations

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  19. US 10098910

    Peroxide formulations and methods and applicators for using the same

    Aclaris Therapeutics, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

  20. US 10085951

    Curcuminoid formulations and related methods of treatment

    DESIGNS FOR HEALTH, INC. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  21. US 10085974

    Dosage and formulation

    Almirall, S.A. · Granted Oct 2, 2018 · Expires Sep 27, 2038

    granted

  22. US 10076505

    Inhalation formulations of Treprostinil

    United Therapeutics Corporation · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  23. US 10072086

    Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  24. US 10058554

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.